Biomarkers in blood and plasma can be used to predict rheumatoid arthritis-associated interstitial lung disease more ...

Efforts to more precisely select appropriate therapy for individual patients with rheumatoid arthritis have not yet yielded a ...

There is a link between rheumatoid nodules and rheumatoid factor (RF), a protein that many people with RA have in their blood. Anti-citrullinated protein antibodies (ACPAs), which are antibodies ...

Increasing wildfire incidence, along with greater overall air pollution, may be contributing to risks for rheumatoid arthritis and RA-associated interstitial lung disease, according to findings ...

Rheumatoid arthritis (RA) commonly causes joint pain, swelling, and inflammation. However, some people with RA will develop skin rashes. These can occur due to hives, vasculitis, and many other ...

A PROSPECTIVE cohort study has identified serum biomarkers that may predict the risk of progression in rheumatoid arthritis-associated interstitial lung disease (RA-ILD), offering valuable tools for ...

The death of a former England footballer may have been linked to his career, an inquest has heard. Trevor Whymark, a centre forward who scored 104 goals in 335 games for Ipswich Town in the club's ...

Although the origin of rheumatoid arthritis (RA ... by contributing to joint and tissue destruction. Placenta growth factor (PIGF), another cytokine, has been thought to be critical for a new ...

The following is a summary of “Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study,” published ...

Overall, 118 (38.4%) cases experienced pulmonary fibrosis progression. We found that baseline DLco% pred (OR 0.92; 95% CI, 8.93–0.95) was a protective factor for ILD progression, whereas combined ...

Connective tissue diseases (CTDs), including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic ... Based on the decision tree, KL-6 is an important factor for evaluating ILD. In ...